Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2314
Last updated 2020-09-18
Summary
The aim of the Danish Organization for Randomized Trials with Clinical Outcome (SORT OUT) is to compare the safety and efficacy of the sirolimus eluting ORSIRO stent and the biolimus-eluting NOBORI stent in a population-based setting, using registry detection of clinically driven events
Conditions
- Coronary Artery Disease
- Ischemic Heart Disease
Interventions
- DEVICE
-
Drug-eluting stent
Sponsors & Collaborators
-
Odense University Hospital
lead OTHER
Principal Investigators
-
Jens F Lassen, MD DMSci · Aarhus University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2015-02-28
- Completion
- 2021-02-01
Countries
- Denmark
Study Locations
More Related Trials
-
SORT-OUT V - Randomised Clinical Comparative Study of the Nobori and the Cypher Stent.
NCT01254981 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention
NCT06692140 ·Status: RECRUITING ·Phase: NA
-
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
NCT01826552 ·Status: COMPLETED ·Phase: PHASE4
-
Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
NCT01516723 ·Status: UNKNOWN ·Phase: PHASE3
-
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT02039739 ·Status: COMPLETED
-
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
NCT07098195 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The OCT SORT-OUT VIII Study
NCT02253108 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
NCT01594736 ·Status: COMPLETED ·Phase: PHASE4
-
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
NCT01995487 ·Status: COMPLETED ·Phase: NA
-
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
NCT01443104 ·Status: COMPLETED ·Phase: NA
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
NCT00418067 ·Status: COMPLETED ·Phase: PHASE4
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
The SOURT OUT IV TRIAL
NCT00552877 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-III All-comers Orsiro Safety and Performance Registry
NCT01553526 ·Status: UNKNOWN
-
Everolimus Stent in Patients With Coronary Artery Disease (CAD)
NCT01182649 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions
NCT02542007 ·Status: COMPLETED ·Phase: NA
-
Limus Eluted From A Durable Versus ERodable Stent Coating
NCT00389220 ·Status: COMPLETED ·Phase: NA
-
First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions
NCT01214148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA